A Van Bodegraven

452 total citations
10 papers, 328 citations indexed

About

A Van Bodegraven is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, A Van Bodegraven has authored 10 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 3 papers in Surgery and 3 papers in Epidemiology. Recurrent topics in A Van Bodegraven's work include Inflammatory Bowel Disease (6 papers), Microscopic Colitis (2 papers) and Eosinophilic Esophagitis (2 papers). A Van Bodegraven is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Microscopic Colitis (2 papers) and Eosinophilic Esophagitis (2 papers). A Van Bodegraven collaborates with scholars based in Netherlands, Germany and United Kingdom. A Van Bodegraven's co-authors include Chris J. Mulder, M.A.E. de van der Schueren, Nicolette Wierdsma, Annemiek J. Linn, Liset van Dijk, Godefridus J. Peters, Agnes I. Veldkamp, Nanne K.H. de Boer, Markus F. Neurath and Berrie Meijer and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Gastroenterology.

In The Last Decade

A Van Bodegraven

9 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Van Bodegraven Netherlands 4 167 127 109 95 52 10 328
Carina Peyrin-Biroulet France 5 76 0.5× 220 1.7× 154 1.4× 329 3.5× 23 0.4× 6 476
Brian Egan United States 12 81 0.5× 53 0.4× 178 1.6× 18 0.2× 17 0.3× 29 339
Vincent Biank United States 11 27 0.2× 134 1.1× 236 2.2× 163 1.7× 18 0.3× 25 491
Smaragdi Fessatou Greece 11 83 0.5× 56 0.4× 143 1.3× 56 0.6× 26 0.5× 30 378
Ewa Toporowska‐Kowalska Poland 14 88 0.5× 130 1.0× 156 1.4× 194 2.0× 91 1.8× 51 541
Anat Guz‐Mark Israel 10 99 0.6× 240 1.9× 113 1.0× 258 2.7× 71 1.4× 35 481
Zoran Leković Serbia 9 121 0.7× 71 0.6× 70 0.6× 60 0.6× 34 0.7× 45 264
Víctor Manuel Navas‐López Spain 12 49 0.3× 214 1.7× 195 1.8× 304 3.2× 73 1.4× 88 470
Simon Chin New Zealand 11 47 0.3× 134 1.1× 243 2.2× 96 1.0× 68 1.3× 25 386
Sara Cococcia Italy 10 78 0.5× 90 0.7× 137 1.3× 52 0.5× 11 0.2× 20 330

Countries citing papers authored by A Van Bodegraven

Since Specialization
Citations

This map shows the geographic impact of A Van Bodegraven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Van Bodegraven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Van Bodegraven more than expected).

Fields of papers citing papers by A Van Bodegraven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Van Bodegraven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Van Bodegraven. The network helps show where A Van Bodegraven may publish in the future.

Co-authorship network of co-authors of A Van Bodegraven

This figure shows the co-authorship network connecting the top 25 collaborators of A Van Bodegraven. A scholar is included among the top collaborators of A Van Bodegraven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Van Bodegraven. A Van Bodegraven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Boer, Nanne K.H. de, Melek Simsek, Berrie Meijer, et al.. (2023). Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel disease. Gut. 72(10). 1985–1991. 3 indexed citations
2.
Romberg‐Camps, Mariëlle, A Van Bodegraven, J Haans, et al.. (2021). Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial. BMJ Open. 11(5). e042885–e042885. 1 indexed citations
3.
Romberg‐Camps, Mariëlle, A Van Bodegraven, Liekele E. Oostenbrug, et al.. (2018). DOP034 Assessment of direct healthcare cost drivers of Crohn’s disease in a Dutch population-based cohort study shows a major shift. Journal of Crohn s and Colitis. 12(supplement_1). S054–S055.
4.
Jong, Mechteld C. de, Mariëlle Romberg‐Camps, Marco C. Becx, et al.. (2017). OP017 Telemedicine enables a safe shift from examination room based care to personalised care for inflammatory bowel disease: a pragmatic randomised multicenter trial with myIBDcoach. Journal of Crohn s and Colitis. 11(suppl_1). S10–S11. 2 indexed citations
5.
Jong, Andrea E. van der Meulen‐de, Mariëlle Romberg‐Camps, Marco C. Becx, et al.. (2017). Telemedicine Enables a Safe Shift from Examination Room Based Care to Personalized Care for Inflammatory Bowel Disease: A Pragmatic Randomized Multicenter Trial With Myibdcoach. Gastroenterology. 152(5). S186–S186. 2 indexed citations
6.
Meij, Tim de, et al.. (2015). P711. Metabolic dysbiosis concept and its biomarkers in ulcerative colitis and celiac disease. Journal of Crohn s and Colitis. 9(suppl 1). S437–S437. 1 indexed citations
7.
Wierdsma, Nicolette, et al.. (2013). Vitamin and Mineral Deficiencies Are Highly Prevalent in Newly Diagnosed Celiac Disease Patients. Nutrients. 5(10). 3975–3992. 196 indexed citations
8.
Linn, Annemiek J., et al.. (2012). Words that make pills easier to swallow: a communication typology to address practical and perceptual barriers to medication intake behavior. Patient Preference and Adherence. 6. 871–871. 45 indexed citations
9.
Boer, Nanne K.H. de, et al.. (2009). On Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease; Pharmacology, Pharmacogenomics, Drug Intolerance and Clinical Relevance. Current Drug Metabolism. 10(9). 981–997. 40 indexed citations
10.
Bodegraven, A Van. (2001). Hemostatic imbalance in active and quiescent ulcerative colitis. The American Journal of Gastroenterology. 96(2). 487–493. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carina Peyrin-Biroulet Breakdown of academic impact, for papers by Brian Egan Breakdown of academic impact, for papers by Vincent Biank Breakdown of academic impact, for papers by Smaragdi Fessatou Breakdown of academic impact, for papers by Ewa Toporowska‐Kowalska Breakdown of academic impact, for papers by Anat Guz‐Mark Breakdown of academic impact, for papers by Zoran Leković Breakdown of academic impact, for papers by Víctor Manuel Navas‐López Breakdown of academic impact, for papers by Simon Chin Breakdown of academic impact, for papers by Sara Cococcia
Rankless by CCL
2026